Medical News

RSS

Two GOP judges will be on health law's next review panel

After facing a favorable panel of judges during its first appeals-court defense of the federal health care law, the Obama administration will face two judges appointed by Republican presidents during the next major case on the law's constitutionality.

18 May 2011

Tips to get better sleep

Your life is already tense — teens rebelling, house under renovation, work life in overload, bills piling up, elderly parents declining — yet the demands requiring your attention and time continue to grow, overflowing into sleep-time territory. Oftentimes, mass marketing's solutions to women's challenging lifestyles focus on quick fixes and more consumer goods.

18 May 2011

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

Amgen today announced primary results of a pivotal Phase 3 trial demonstrating that XGEVA significantly increased bone metastasis-free survival for more than four months in men with castrate-resistant metastatic prostate cancer that has not yet spread to bone.

18 May 2011

TurboCharged weight-loss book now available for readers in France

TurboCharged, a new book by brother and sister co-authors Dian Griesel, Ph.D. and Tom Griesel, outlines a revolutionary 8-step rapid fat-loss program requiring no aerobic exercise, supplements or special equipment.

18 May 2011

New experimental vaccine prevents infection of horses with deadly Hendra virus

CSIRO scientists have shown that a new experimental vaccine helps to protect horses against the deadly Hendra virus. Dr Deborah Middleton from CSIRO's Australian Animal Health Laboratory (AAHL) will announce the successful progress to develop the vaccine at the Australian Veterinary Association conference in Adelaide today.

18 May 2011

Impaired ability to handle oxidative stress may contribute to asthma development

An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.

18 May 2011

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C.

18 May 2011

Endo and Bioniche present Urocidin Phase III trial preliminary results at 2011 AUA annual meeting

Endo Pharmaceuticals and Bioniche Life Sciences today presented Phase III trial results for the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin, during a podium presentation at the 2011 American Urological Association annual meeting in Washington, D.C.

18 May 2011

The Incubation Factory, UMDNJ and NJIT partner to commercialize personal tonometer for glaucoma

NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, PhD, and Robert Fechtner, MD, director of the glaucoma division at UMDNJ.

18 May 2011

Thirty years of AIDS

Thirty years ago next month, the CDC released the first report on a mysterious disease among gay men in Los Angeles. The AIDS epidemic had begun. It has since claimed the lives of an estimated 600,000 Americans and is currently ravaging Africa.

18 May 2011

Leucine deprivation triggers apoptosis in melanoma cells

Whitehead Institute researchers have found that depriving human melanoma cells of the essential amino acid leucine can be lethal to the cells, suggesting a possible strategy for therapeutic intervention.

18 May 2011

Study offers new understanding of cell signaling networks tied to diabetes and cancer

Researchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological processes involved in major diseases such as diabetes and cancer. This work could help scientists design drugs to battle these disorders.

18 May 2011

State roundup: Gov. Brown offers revisions to health budget

A new state department would be formed to manage California's violence-plagued mental hospitals under a proposal in the governor's Monday budget revision. The push to create a Department of State Hospitals — and eventually do away with the Department of Mental Health, which now oversees the facilities — comes as lawmakers and employee unions press for changes to address increasing patient assaults on fellow patients and staff.

18 May 2011

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Astellas Pharma US, Inc., U.S. subsidiary of Astellas Pharma Inc., today announced the results of a pivotal phase III clinical trial for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), which show mirabegron significantly improves key OAB symptoms – urinary incontinence and frequency of micturition compared with placebo.

18 May 2011

Thermo Fisher Scientific acquires Dionex

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.

From Thermo Fisher Scientific Inc. 18 May 2011

Viewpoints: Gingrich fallout; Sebelius, Matsui on Medicare reform; physicians on their rights

The Republican Presidential campaign is off to a slow start, but judging by the last week not slow enough. First Mitt Romney defends his ObamaCare prototype in Massachusetts, and now Newt Gingrich has decided to run against House Republicans on Medicare. They must be loving this at the White House.

18 May 2011

USPTO issues notice of allowance to Vermillion's Peripheral Artery Disease biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Panel of Biomarkers for Peripheral Artery Disease" to the company.

18 May 2011

Cytonet receives FDA orphan drug designation for liver cell infusion to treat urea cycle disorders

International biotechnology firm Cytonet, which is investigating a liver cell infusion of donated human liver cells for the treatment of urea cycle disorders in young children, announced it has been granted orphan drug designation by the U.S. Food and Drug Administration.

18 May 2011

Opinion: Innovative funding mechanisms needed for global development

"Innovation in development finance doesn't preclude innovation in other areas of development policy. In fact, they must go hand in hand," Jamie Drummond, executive director of ONE, writes in a post on the Guardian's "Poverty Matters Blog," noting findings from his group's annual report.

18 May 2011

$Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery$

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Avedro, Inc. today announced the completion of all one-year follow-up visits for patients enrolled in its two multi-center Phase III studies evaluating the safety and efficacy of corneal collagen cross-linking for the treatment of progressive keratoconus and ectasia following refractive surgery.

18 May 2011

Medical News

Two GOP judges will be on health law's next review panel

Tips to get better sleep

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

TurboCharged weight-loss book now available for readers in France

New experimental vaccine prevents infection of horses with deadly Hendra virus

Impaired ability to handle oxidative stress may contribute to asthma development

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

Endo and Bioniche present Urocidin Phase III trial preliminary results at 2011 AUA annual meeting

The Incubation Factory, UMDNJ and NJIT partner to commercialize personal tonometer for glaucoma

Thirty years of AIDS

Leucine deprivation triggers apoptosis in melanoma cells

Study offers new understanding of cell signaling networks tied to diabetes and cancer

State roundup: Gov. Brown offers revisions to health budget

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Thermo Fisher Scientific acquires Dionex

Viewpoints: Gingrich fallout; Sebelius, Matsui on Medicare reform; physicians on their rights

USPTO issues notice of allowance to Vermillion's Peripheral Artery Disease biomarker patent

Cytonet receives FDA orphan drug designation for liver cell infusion to treat urea cycle disorders

Opinion: Innovative funding mechanisms needed for global development

Avedro completes two Phase III corneal cross-linking studies in keratoconus, ectasia post-refractive surgery

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News